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ABSTRACT 
IMMUNOLOOICAL RESPONSE OF RATS TO MYCOPLASMA ARTHRITIDIS 
A sensitive assay for titration of antibodies which inhibit the 
metabolism of arginine by H. arthritidis was developed. Sera col-
lected from rabbits immunized with H. arthritidis inhibited arginine 
metabolism when diluted 1:1600. The addition of fresh guinea pig 
serum enhanced the metabolic inhibition (MI) titer at least sixteen 
fold while heated guinea pig serum did not affect the titer of the 
rabbit antiserum. It was shown that rats did not produce detectable 
metabolic inhibiting antibodies to H. arthritidis. but did produce 
complement fixing antibodies in high titers. Preliminar,y experiments 
disclosed that uninoculated rats could be passive~ protected against 
an intr~venous challenge of live H. arthritidis when given serum from 
rats that had recovered from polYarthritis. The rat serum used had a 
high titer of complement fixing antibodies and no detectable MI anti~ 
bodies. 
Rats were injected intravenouslY with varying numbers of Ho 
arthritidis. Rats inoculated with the larger doses of organisms 
developed po~arthritis to a greater extent than those injected with 
smaller doses. It was shown that complement :fixing antibody occurred 
in the sera of rats injected with H. arthritidis within three days 
after inoculation. Sera from rats which developed polYarthritis 
general~ fixed complement at a greater dilution than sera of rats 
which did not develop po~arthritis. 
It was also shown that rats which had recovered from poly-
arthritis were resistant to intravenous challenge with ~. arthritidiso 
Only one of fourteen rats inoculated intravenously with~. arthritidis 
developed polyarthritis when ohallenged. 
x 
INTRODUCTION 
Recently it was conclusively shown that mycoplasma cause disease 
in man. In 1962, the agent of cold-agglutinin-positive atypical 
pneumonia was shown to be a species of mycoplasma (Chanock et aloe 
1962). 
~coplasma in man have been associated with nongonococcal 
urethritis (Ford et al., 1962, 1963; Freundt, 1953; Klieneberger-
Nobel, 1960; Helen and Linnros, 1952; Salaman et al., 1946; and 
Shepard, 1954), leukemia (Barile et al., 1966; Girardi et al., 1965; 
Hayflick and Koprowski, 1965: and Hummeler et al., 1965), erythema 
multif orme, conjunctivitis and urethritis (stevens-Johnson syndrome, 
Katz et ~l., 1967 and Sieber et al., 1967), nonspecific urethritis, 
arthritis and conjunctivitis (Reiter's syndrome, Nicol and Edward, 
1953; Oates et al., 1959; Schaffarzick and HankIe, 1953; and Wal-
lerstein et al., 1946), exudative pharyngitis (Hutson et al., 1965), 
tonsillitis (MUfson et al., 1965), and arthritis (Ford, 1960; Jonsson, 
1961; Wallerstein et al •• 1946). Conclusive proof as to their direct 
involvement in these diseases is lacking. 
Polyar~hr1tis is a common manifestation of a mycoplasmal infec-
tion in lower animals. It occurs in the cow (Moulton et al., 1956), 
goat (Cordy and Adler, 1960), sheep (Cordy and Adler, 1960), fowl 
(Adler, 1959: Olson, 1959), pig (Aho et al., 1966; Lecce, 1960), 
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mouse (Klieneberger, 1940; Sabin, 1939), and rat (Collier, 1939b; 
Preston, 1942; and Woglom and Warren, 1938a). Po~arthritis often 
occurs in Reiteras syndrome and Stevens-Johnson syndrome in man, but 
absolute proof of the causative agent of this disease in man is lack-
• ing. 
Since po~arthritis is such a common manifestation of myco-
plasma infection and since this disease occurs naturally in rats, a 
study of this manifestation could contribute much to our understand-
ing of the pathogenesis of ~coplasma disease in animals and possibly 
in man. Polyarthritis can be produced in rats following intravenous 
injection of a large dose of Mycoplasma arthritidis. Thus we have 
a convenient experimental model for the study of mycoplasma infec-
tion. The rat is a useful experimental animal in which to study the 
parameters of mycoplasma infection. 
It was dec~ded that an investigation of polyarthritis caused 
by H. arthritidis in rats should be carried out. Serological 
responses of the rats to infection by H. arthritidis were given 
special emphasis in the study reported in this thesis. 
LITERATURE REVIEW 
I. POLYARTHRITIS II RATS 
In 1938 Wog1om and Warren described an agent which they thought 
to be a virus. The agent was encountered in a transplantable rat 
sarcoma and caused extensive necrosis when injected subcutaneously 
into experimental laboratory rats. These workers were unable to 
grow the agent 1!l vitro, but were able to transfer the agent to other 
rats by injection of ten per cent extracts of the abscess in physio-
logical saline. When the extract was injected intravenously into 
rats, their feet became edematous and reddened within three days and 
abscesses developed several days later. The agent passed through a 
Berkefeld B filter, a filter known to retain most bacteria. 
nieneberger (1938) devised a medium which she used to isolate 
mycoplasma (Nowak, 1929) from. the enlarged submaxillary gland of a 
rat. She designated the organism. Jl.I. and showed the organism. to be 
different trom other mycoplasma by agglutination studies. Using her 
special medium, fiieneberger was able to isolate an organism similar 
to ~ trom the lesions which developed in rats atter injection of 
Woglom's pyogenic agent (nieneberger, 1938, 1939). Woglom and 
Warren later confirmed the presence of mycoplasma in the lesions 
caused by their pyogenic agent (Woglom and Warren, 1939). 
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In a series of papers, Collier and others working with him 
(Beeu~es, 1940; Beeu~es and Collier, 1942; Collier, 1939a; 1939b; 
1939c; 1939d; 1940; and Collier and Esseveld, 1938) reported a 
spontaneo~ po~arthritis of wild rats which could be transmitted 
to experimental laboratory rats. The agent described was identical 
in morphology to the ~ organism described by Klieneberger (1940) 
and exhibited a similar pathogenicity. 
Findlay ~t ale (1939) also isolated a mycoplasma from the 
affected joints of experimental laboratory rats which had contracted 
polyarthritis natural~. They identified the organism as "L7," but 
the organism was subsequent~ found by nieneberger (1940) to be 
serologically identical with ~. 
The pathological changes of po~arthritis in rats were described 
by Findlay et ale (1939). In the ear~ stages there was infiltration 
around the joint with polymorphonuclear leucocytes and large mono-
nuclear cells. Later, fibroblasts appeared and finally the joint 
oavity was invaded with disappearance of articular cartilage and 
absorption and disorganization of the epiphysis. 
A disease in members of a large breeding stock of rats used 
for experimental purposes was described by Rhodes and van Rooyen 
(l939). The symptoms of the disease were similar to those caused 
by Klieneberger's~. Rhodes and van Rooyen did not attempt to 
cultivate the organism on a medium which would permit growth of 
mycoplasma t but were able to transmit the disease by injecting pus 
5 
trom infected rats into the toot pads ot healthy rats. An attempt 
was made to transmit the infection in the laboratory b.Y placing 
infected rats in the same cage as healthy ones, but the infection 
did not spread. 
In 1941, Sabin suggested the etiological agent of spontaneous 
polyarthritis in the rat (1# of nieneberger, 1940 and L7 of Findlay 
et al •• 1939) be called Murim.yces arthritidis. This name was not as 
well accepted as 1#. 
The genus ~coplasma was established by Edward and Freundt 
(1965) to include the pleuropneumonia-like organisms originally 
described by Bocard et ale (1898). Edward and Freundt proposed the 
name MYcoplasma arthritidis tor the agent ot polyarthritis in rats. 
Preston (1942) noted that arthritis was a trequent complica-
tion of animal diseases known to be caused b,y ~coplasma but was not 
able to culture ~coplasma from joint fluid ot humans with rheuma-
toid arthritis. In studies using !I. arthritidis, he described 
pathological changes in a rat. Following intravenous injection of 
H. arthritidis, the joints become swollen and edematous; the area 
within and around the joint capsule becomes purulent; and the syno&> 
Vial membrane, cartilage and bone around the joint often become 
involved in an acute suppurative process. In this respect, the 
lesion more close~ resembles that seen in pyogenic joint infections 
of man rather than that ot rheumatoid arthritis. The abscess around 
the joint may rupture and heal, leaving a relatively good funct.ion 
in the joint. Ankylosis may occur in joints which have undergone 
marked destruction of the cartilage. 
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Parks and Wrigley (1951) also used histiological techniques 
to show that rheumatic diseases of man were different from experi-
mental polyarthritis in rats. 
The role of ~coplasma in genitourinary and joint diseases 
was discussed by Dienes et ale (1948). The presence of fever, 
chills and malaise, along with infection of the joints of several 
male pat~ents from which mycoplasma had been isolated from the 
genitourinary tract led to the suggestion that mycoplasma produce 
a generalized human infection with joint localization. 
II. IMMUNE RESPONSE OF RATS 
Although the histiological aspects of rat infections of Ho 
arthritidis have been discussed thoroughly in the literature, little 
has been reported on antibody response and immunity of the rat to 
challenge with H.arthritidis. 
Resistance to challenge with Ho arthritidis was well estab-
lished by the seventh day after subcutaneous or intravenous inocu-
lation of H. arthritidis (Woglom and Warren, 1938a). Sera collected 
from rats inoculated one to two weeks previously with the agent 
which caused polyarthritis would not neutralize the agent when com-
bined with varying numbers of the organism and incubated at 37°C for 
ninety minutes. Rats inoculated intratesticularly with the immune 
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serum-~coplasma mixture reacted similarly to normal rats injected 
with ~coplasma Which had not been mixed with rat antiserum. 
In 1939. Collier (1939b) reported that both laboratory and 
field rats immunized with the agent of polyarthritis were immune 
to challenge with the same organism. Even rats which did not have 
the symptoms of polyarthritis were immune to challenge with the 
organism. 
As with Woglom and Warren (1938a). Collier could not find 
neutralizing antibodies in the serum of immune rats. 
Two rat polyarthritis strains of H. arthritidis were recently 
investigated by Klieneberger-Nobel (1960). An encapsulated abscess 
was formed at the site of subcutaneous inoculation of the organism. 
The abscess increased in size during the first three to four weeks 
and regressed slowl,y. Complement fixation antibody titers rose to 
1:2.500 during the first four to five weeks after inoculation and 
then declined gradua~ during the next eighteen weeks. 
Lemcke (1961) used a strain of ~coplasma which was less viru~ 
lent than the organisms tested by Klieneberger-Nobel (1960). The 
complement fixation titer reached a maximum of 1:320 four to five 
weeks after subcutaneous injection of the organisms. She attempted 
to isolate ~coplasma from rats which had been inoculated with the 
organisms. There was a correlation between the presence of ~co­
plasma dell10nstrated by culture and the occurrence in the blood of 
antibodies specific for the infecting strain. When mycoplasma were 
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present in the rat, complement fixing antibodies specific for that 
organism Qould be demonstrated. The titer of the serum was directly 
related to the severity of the infection. The titer increased as 
the severity of the disease increased. 
Lemcke (l96l) suggested that since there was a direct relation-
ship between the presence of ~coplasma in the rat and antibody 
specific for that organism, then specific antibody found in man 
could be a significant indicator of ~coplasma infection. 
It is evident from this review of literature that more infor-
mation on the role and significance of antibody in rat polyarthritis 
caused by ~coplasma is needed to more fully understand polyarthritis 
in rats. 
MATERIALS AND METHODS 
10 MEDIA 
A. Media.!2!. Maintenance of Kycoplasma 
The medium used for isolation and maintenance of ~coplasma 
organisms was described by Taylor-Robinson et al. (1966). 
Another solid medium. base agar. was prepared by a modifica= 
tion of the method described by Cole and Pease (1967). It consisted 
of l~ proteose peptone No.3 (Dirao). 0.125% yeast extract (BBL)9 l~ 
Lab-Lemco (Oxoid beef extract), 0.5% sodium chloride and 1% Ionagar 
No.2 (Oxoid). The mixture was adjusted to pH 7.8 with 40% sodium 
hydroxide and autoclaved at 1210 C for 15 minutes, after which it was 
placed in a 56°C water bath for two hours to allow any pr~cipitate 
which developed to settle. The supernatant was decanted into a 
sterile flask and 15% unheated horse serum. 2.5% fresh yeast extract 
and 1000 units/ml Penicillin G were added. The medium was mixed 
thoroughly and poured into sterile plastic petri dishes. The plates 
o 
were stored in metal containers at 4 C until used. Fresh yeast 
extract was prepared by a modification of the method described by 
Taylor-Robinson et al. (1963). Baker·s yeast (100 grams) was added 
to 300 ml of distilled water. The mixture was boiled until one-third 
of the original volume remained. After centrifugation at 25,000 x g 
for 15 seconds, the supernatant yeast extract was sterilized by 
10 
filtration through a Seitz filter. The yeast extract was stored at 
_20oC until used. 
~. Medium ~ Metabolic Inhibition (MI) Tests 
The medium used for the metabolic inhibition test was a modifi= 
cation of that described by Taylor-Robinson et ale (1966). It con-
sisted of 7 parts of Difco PPLO broth, 2 parts of unheated horse 
serum, 1 part of fresh yeast extract, 1% ~arginine HCl, 0.002% 
phenol red and 1000 units/ml Penicillin G. The arginine broth 
medium was adjusted to pH 7.2 with hydrochloric acid. 
C. Rabbit Infusion Broth 
The organisms used for immunization of rabbits were grown in 
a rabbit muscle infusion broth. The infusions were prepared by the 
method described by Taylor-Robinson et a~. (1963). Eight ml of 
distilled water were added to each gram of rabbit muscle. The mix= 
ture was finely ground in a Waring blender. After blending, the 
mixture was heated to boiling and the infusion was cooled and fil~ 
tered through gauze and then filter paper. Peptone (l~; Difco) and 
0.5% sodium chloride were added and the pH adjusted to 7.8 with 40~ 
sodium hydroxide or 10% hydrochloric acid. The preparation was 
sterilized by autoclaving at 12loC for 15 minutes. Two ml of choles-
terol (Fisher Scientific Company) solution were added to each 100 ml 
of rabbit infusion. The steroid was prepared by dissolving 100 mg 
of cholesterol in a small quantity of absolute ethanol and adding 
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the solution to 100 ml of hot distilled water. Rabbit infusion was 
enriched with 7.5% normal rabbit serum. 
D. Media ~ Biochemical Identification of MYcoplasma 
Unknown ~coplasma were tentatively identified by their bio-
chemical properties. 
"Incomplete mediumH consisted of 80 to 85~ Difco PPLO broth, 
10~ unheated horse serum. 5% fresh yeast extract and 1000 units/ml 
of Penicillin G. For solid media PPLO broth was replaced with Difco 
PPID agar. 
E. Glucose Broth 
Glucose broth was prepared by adding 10 ml of Seitz filtered 
10~ glucose and 2 ml of 1:1000 phenol red to 90 ml of sterile incom-
plete medium. The broth was distributed to sterile screw-cap culture 
tubes (15 x 100 mm) in 2 ml amounts. Three drops of a four-day 
culture of mycoplasma in PPLO broth were used to inoculate the glu-
cose broth. The tubes were incubated aerobically 4 to 7 days and 
checked for color change of the indicator. The test was considered 
positive if the indicator changed in color from red to yellow. 
F. Arginine Broth 
Arginine broth was prepared by mixing 10 ml of sterile (12l0 C 
for 15 minutes) l~ L-arginine HCl with 90 ml incomplete medium.. 
The arginine broth was dispensed into sterile screw-cap culture 
tubes in 2 ml amounts and inoculated as for the glucose broth. After 
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4 to 7 days of incubation under aerobic conditions, a drop of the 
arginine broth culture was mixed with a drop of Nessler's reagent on 
a petri dish. An orange-brown coloration indicated arginine had been 
deaminated and ammonia had been released into the medium. 
G. ~ Yolk ~ 
Egg yolk agar (McClung and Toabe, 1947) was prepared by mixing 
10 ml of Oxoid egg yolk with 90 ml of incomplete medium. The molten 
agar was poured into plastic petri dishes and placed in a 37°C incu-
bator with the lids raised to allow evaporation of excess moisture. 
The agar was inoculated with two drops of four-day-old mycoplasma 
broth culture or with organisms growing on a small section of base 
agar. The plates were incubated at 37°C for 4 to 7 days under aerobic 
conditions and checked for lipolytic activity indicated by an oily 
film on the agar surface. 
H. Benzidine Blood ~ 
Benzidine blood agar was prepared by adding 4 ml sterile sheep 
blood and 1 ml of 1% benzidine in acetic acid to 95 ml of incomplete 
agar medium. The benzidine blood agar plates were poured and inocu~ 
lated as for the egg yolk agar plates. After 4 to 7 days of aerobic 
incubation at 37°C the plates were checked for growth of the myco~ 
plasma and production of peroxide as indicated by a brown-black color 
beneath or around the mycoplasmal growth. 
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I. Triphenyl Tetrazolium Chloride !&!!: 
Triphenyl tetrazolium chloride (TTC) agar (Somerson and Morton. 
1953) was prepared by mixing 1 m1 of O.5f, TTC with 99 m1 of incom-
plete mediUD'l. Agar plates were prepared and inoculated as described 
previously. Each organism to be tested was inoculated onto two TTC 
agar plates. One was incubated aerobically at 37°C and the other 
anaerobically at the same temperature. The TTC plates were checked 
for growth of the ~coplasma and for reduction of TTC in or around 
the ~coplasma. colonies. Triphenyl tetrazolium chloride which is 
colorless in the oxidized state becomes red when reduced. 
J. Mycoplasma Strains Used 
Several strains of ~coplasma isolated from the ~ogenital tract 
of man cause polyarthritis when injected intravenously into rats. 
These organisMS have been referred to in the literature as H. hominis 9 
type II. 
Lemcke (1964). Lemcke and Csonka (1962) and Pease (1965) used 
complement fixation and gel double diffusion tests respectively to 
demonstrate antigenic identity of .H. arthritidis and 11. hominis. 
type n. Edward (1954) and Edward and Freundt (1956) found that 
these organisms were the same on the basis of physiology and mor-
phology. Cole et al. (1967) reported that the virulence of M. 
hominis. type n and H. arthritidis strains maintained on artificial 
media was identical. !t. hominis. type nand }1. arthritidis are also 
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indistinguishable by the agar column hybridization technique used 
to estimate genetic relatedness (McGee et al., 1967). Recently 
Edward and Freundt (1965) proposed that H. hominis, type II be 
reclassified as H. arthritidis. 
Since H. arthritidis and H. hominis, type II are indistin-
guishable on the basis of antigenicity, physiology, morphology, 
virulence and genetic homology, the two species will be oonsidered 
the same by the author. H. hominis, type II will be referred to as 
H. arthritirlis in this thesis. 
H. arthritidis, strain 14152, and H. arthritidis, strain 14124, 
were obtained from the American Type Culture Collection (Rockville, 
Md.). Frozen cultures of the organisms were used as stock cultures 
in these studies. 
H. arthritidis, strain DL, was isolated by Laura Rowland and 
James Cahill (University of Utah, Salt Lake City, Utah) from the 
joint of a Long-Evans, strain L, black and white rat suffering from 
polyarthritis. 
H. arthritidis, strain 158, was obtained from Dr. Miohael F. 
Barile (Division of Biologic Standards, Bethesda, Md.) and was pas-
saged ten times by subcutaneous inoculation in white laboratory rats o 
K. Rabbit Hyperimmune Sera 
The techniques of Pease and Laughton (1965) and MOrton and 
Roberts (1966) for production of rabbit antisera were modtfied. One 
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or two liters of rabbit infusion broth were inoculated with 100 to 
200 ml of a 3 to 4 day culture of mycoplasma. The culture was incu-
bated at 37°C for three days or until growth was noticeable. The 
organisms were concentrated in a Servall centrifuge at 27000 g and 
washed three times with saline (0.85~ sodium chloride). The organ-
isms were resuspended in 6 ml of saline and subjected to ultrasonic 
vibration using a sonifier (Branson Sonifier, model S~75) set on the 
one or two position and run at 2.5 to 3 milliamperes for 2 to 3 min-
utes. Hyperimmune rabbit sera was prepared either by the Pease (1965) 
or Morton and Roberts (1966) methods of immunization. 
The Pease method consisted of two suboutaneous injections (each 
0.5 ml of antigen + 0.5 ml of Freund's oomplete adjuvant) followed in 
two weeks by a graded series of intravenous injections of antigen 
alone (0.5. 0.75 and 1 ml) over a three-day period. The animals were 
test bled ten days following the final intravenous injection and then 
injeoted intramuscularly with 0.5 ml of antigen suspended in 0.5 ml 
of Freund's oomplete adjuvant when necessary. 
The Morton method employed injections Oli 0.5 ml of antigen 
suspended in 0.5 ml of Freund's complete adjuvant into the hind 
footpads. followed in three weeks by injeotions (0.5 ml of antigen 
+ 0.5 ml of complete Freund's adjuvant) into musoles of the shoulder 
region. Two weeks later the animals were test bled and when neces~ 
sary, the rabbits were injeoted subcutaneous~ with 0.5 ml of antigen 
suspended in 0.5 ml of Freund's complete adjuvant. 
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L. Guinea E!& Serum 
One m1 aliquots of guinea pig serum (BBL) were dispersed into 
small serum bottles and stored at -20oC. Fresh guinea pig serum. was 
used as a source of a heat labile accessory factor in the metabolic 
inhibition test and as a source of complement in the oomplement 
fixation test. 
M. Absorbed Rabbit Immune Serum 
Absorbed rabbit serum was prepared by mixing equal volumes 
of H. arthritidis, strain 14152 antigen and rabbit hyperimmune anti-
serum. The antigen was adjusted such that a 1:20 dilution gave an 
optical density difference of 0.32 on a Bausch and Lomb Spectronic 
20 at wavelength 540 millimicrons. The spectrophotometer was set 
to zero with a water blank. The suspension was stored 4 to 5 days at 
4°C, after whioh the particulate material was removed by centrifuga-
tion. The supernatant fluid was diluted 2:3, giving a final dilution 
of absorbed antiserum of 1:3. The absorbed rabbit serum was then 
heated at 56°c for 15 minutes. 
N. Indirect Hemagglutination Test 
An indirect hemagglutination test for the quantitation of 
antibody to ~coplasma has been developed by Taylor-Robinson et al o 
(1965) based on the procedure described by Friedman and Bennett 
(1957) for the detection of adenovirus antibodies. The procedure 
involved tanning of sheep erythrooytes, sensitizing the cells with 
myooplasma antigen and freezing the oe11s in a dextrose-1aotose 
solution. 
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The test is carried out in the following manner: lVooplasma 
used as antigen were grown in PPLO broth. After 3 to 4 days of inou-
bation at 37°C the suspension of organisms was oonoentrated in a 
Servall oentrifuge at 27,000 x g and the antigen resuspended in 
buffered saline (pH 7.2) oontaining 0.2~ formalin. The organisms 
were subjeoted to ultrasonio vibration using a sonifier (desoribed 
previously). Fresh sheep erythrooytes were washed three times in 
buffered saline and f'tanned" by inoubating a 4% suspension with an 
equal quantity of 1:20,000 tannio aoid (Fisher Soientifio Company) 
in burfel"ec;i saline for ten minutes at 37°C. After washing the tanned 
oe11s three times in buffered saline, a 2~ suspension was prepared 
in buffered saline. The antigen, diluted 1:40 gave an optioa1 den-
sity differenoe of 0.32 on a Bausch and Lomb Spectronio 20 at wave""" 
length )40 mi11imiorons. The speotrophotometer was set to zero with 
a water blank. The antigen was diluted in a two-fold series (start ... 
ing with 1:8) in buffered saline. Aliquots of the dilutions were 
mixed with equal volumes of the 2~ washed tanned cell suspension. 
After 20 minutes of incubation in a water bath at 37°C the suspen-
sion was oentrifuged at 1500 rpm for 10 minutes. The oel1s were 
resuspended in buffered saline with 1:200 normal rabbit serum. 
inaotivated at 56°C for 20 minutes. The suspension was ~gain cen-
trifuged at l500 rpm for ten minutes and resuspended in the 1:200 
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normal rabbit serum to produce a 2~ suspension of sensitized tanned 
sheep erythrocytes. For controls, tanned sheep erythrocytes were 
treated by the same procedure except that buffered saline was sub~ 
stituted for antigen. 
Rabbit antiserum was heated at 56°C for 30 minutes and diluted 
in a two-fold series (starting with 1:50) in 1:200 normal rabbit 
serum. Sensitized sheep erythrocytes (0.5 ml) were added to 0.5 m1 
of serum; incubated 2 hours at 37°C; and then overnight at 4°C. 
The serum titer was considered to be the highest dilution of anti-
serum which caused complete agglutination of the sensitized sheep 
erythrocytes. 
In order to obtain reproducible results, and to reduce the 
time required to set up the tests, a large quantity of sensitized 
sheep erythrocytes was preserved by a modification of the method 
described by Hubert et al. (1963). 
A 4~ suspension of sensitized tanned erythrocytes was prepared 
in 1:200 normal rabbit serum. The suspension was mixed with an equal 
volume of dextrose-lactose solution; the final concentration of the 
dextrose and lactose in the solution being 5% and 7.5~ respectively. 
Aliquots of the sugar-erythrocyte mixture were placed in glass tubes 
and shell frozen in acetone. The cell suspensions were stored at 
-700 C ~til needed, at which time they were thawed rapidly by agi-
tation in a 37°C water bath and centrifuged at 1500 rpm for 10 min-
u.tes. The erythrocytes were washed once in 1:200 normal rabbit 
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serum in buffered saline and resuspended to yield ~ 2~ concentration 
of sensitized sheep erythrocytes in 1:200 normal rabbit serum. The 
indirect hemagglutination test was set up as described in the titra-
tion of the antigen. 
o. Metabolic Inhibition (HI) ~ 
The method is a modification of the metabolic inhibition test 
described by Purcell et ale (1966). All tests were performed in 
two ml screw-cap serum vials. Rabbit antiserum was diluted 1: 10 or 
1:50 in PPLO broth and then heated at 56°C for 15 minutes. 
The test was performed as follows: 0.25 ml of broth medium 
(with arginine) was placed into each tube. Serum saDlples (0.25 ml) 
were added to the first tube of each series and serial two-fold 
dilutions were carried out. A broth suspension of organisms (1,000 
colony forming units in 0.2 ml) was then added to all tubes except 
medium control tubes. When guinea pig serum was used as a source 
of heat labile accessory factor, it was delivered in 0.1 ml amounts 
to each tube. The total volume was brought to 0.9 ml by the addi-
tion of 0.35 ml (0.25 ml when guinea pig serum was used) of broth 
medium. The medium control tubes received an additional 0.2 ml 
to bring the volume of fluid in all tubes to 0.9 ml. The tubes 
were incubated without agitation at 37°C under aerobic conditions. 
Serum titers were recorded when the tubes which contained organisms 
but no antiserum had changed from orange to red (approximately 72 
hours) • The highest serum dilution which prevented a qolor change 
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was recorded as the end point. The addition of specific antiserum 
to the medium inhibits mycoplasma growth and subsequent metabolism 
of arginine. This is manifested by failure of the indicator to 
change color. 
P. Complement Fixation Procedure 
Complement fixation titers of the sera were determined by the 
one-fifth quantitative serum test of Kolmer and Boerner (1945). 
Antigen was prepared as described in the indirect hemagglu-
tination procedure. The antigen was diluted to give an optical 
density difference reading of 0.16 on a Beckman model DB at wave-
length 540 millimicrons. The spectrophotometer was set to zero 
with a water blank. All dilutions in the test were made with 
modified barbital buffer, as described by Campbell et ale (1962). 
Q. Quantitative Complement Fixation Test 
Serial two-fold dilutions of the rat serum (1:10 to 1:40,960) 
contained in 0.2 ml were prepared in 1mB. Antigen (0.1 ml) was 
added to each tube. Ten to thirty minutes later, two units of com-
plement contained in 0.2 ml were added. The tubes were incubated 
overnight at 4°C, followed by 10 to 15 minutes in a J7°C water bath. 
Two units of hemolysin (0.1 ml) and 0.1 ml of a 2~ sheep e:rythrocyte 
suspension was added to each tube. The tubes were shaken and incu-
bated in a J7°C water bath until the erythrocytes in the control 
tube containing complement hemolysin and erythrocytes were 
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completely lysed. The reciprocal of the greatest dilution was con-
sidered the titer of the serum. 
R. Preparation ~ Frozen Cultures for Metabolic Inhibition Tests 
All strains of mycoplasma were grown on PPLO or base agar. 
Isolated colonies were picked and replated two or three times to 
insure a pure culture of mycoplasma. A section of base or PPLO 
agar (approximately one inch square) with young colonies of the 
organism was placed in arginine broth and incubated for 1 to 2 days 
at 37°C under aerobic conditions. One ml aliquots of the growing 
culture were placed into 2.5 ml serum vials and stored at _20oC 
until used. 
S. Determination of the Colony Fo£M1ng Units g! Mycoplasma 
The number of colony forming units (CFU) was determin~d by 
a modification of the method described by Miles and Misra (1938). 
The procedure consisted of counting colonies which developed from 
measured drops of culture dilutions seeded on well-dried agar 
plates. Serial ten-fold dilutions were made of the suspension 
(10-1 to 10-5)\0 PPLO and base agar plates were placed in an incu-
bator for 15 to 30 minutes with the lid raised to dry the agar 
enough to absorb a 0.005 ml drop of suspension in 15 to 20 minutes. 
A Yale disposable 25g 5/8" needle on a glass 1 ml syringe delivers 
approximately 200 drops/ml. or 0.005 ml/drop. A series of three 
drops for each dilution was placed on the agar plate. The plates 
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were inoubated at 370 0 for 3 to 4 days or until colonies had formed. 
The number of viable organisms was determined by taking the average 
of the three counts of that dilution which had 30 to 50 colonies per 
drop, multiplying by the number of drops in 1 ml, then by the dilu-
tion factor. 
T. Isolation of Mycoplasma From Rats 
A colony of Long-Evans, strain L, black and white rats which 
frequently ha$ outbreaks of polyarthritis was tested for the pres-
ence of mycoplasma organisms. Blood was collected by cardiac 
puncture from thirty-three adult male rats weighing approximately 
500 grams. The serum was harvested after 24 hours at 4°0 and 
stored at _200 0 for future determination of antibody titers. Five 
of the rats were exsanguinated and autopsied. Samples of lung, 
trachea, bladder, cecal material, liver, spleen, joint, axillary 
or inguinal lymph nodule, heart and kidney were minced and streaked 
onto base agar and placed into PPLO broth. Throat and nasal mucosa 
swabs were also streaked onto base agar and placed into broth. All 
cultures were incubated aerobically at 37°C for 4 to 5 days and ob-
served for growth of mycoplasma. Representatives of the various types 
of mycoplasmas isolated from each culture were streaked onto base agar. 
If more than one colonial type were present, representative colonies 
of each type were again streaked onto base agar. The~e cultures on 
base agar were used to inoculate PPLO broth which was used as the 
inoculum for biochemical tests for identification of the organisms. 
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U. Intravenous Inoculation 2! Rats with MYcoplasma arthritidis 
A broth culture of H. arthritidis, strain 1,58, was concentrated 
by centrifugation in a Servall centrifuge at 27,000 x g and resus-
pended in 8.5 ml of PPID broth. The suspension was divided into two 
tubes and was stored at _20oC. The number o~ CFU in one tube, con-
taining 0.5 ml. was determined using the method of Miles ~ Misra 
(1938). The other suspension was thawed immediatelY prior to inocu-
lation and dilutions were prepared such that 0.5 ml contained approx-
imately 2x109, 2x108 , 2x107, or 2x106 CFU. The number of CFU of these 
dilutions was found to be 6xl09, 6x108, 6xl07, and 6xl06 for 0.5 ml 
when counted immediately prior to injection into rats. 
Holtzman white male rats weighing 100 to 120 grams were divided 
into five groups of seventeen animals and placed in metal cages with 
five or six animals per cage. 
The mycoplasma suspensions (6x109, 6xl08 , 6xl07, or 6xl06 CFU 
in 0.5 ml) or 0.5 ml of PPLO broth were injeoted into rats via the 
caudal vein. 
Polyarthritis was determined by estimating the swelling of each 
joint and the paralysis o~ each limb. The swelling was recorded on a 
scale of 1 to 4 with minimal swelling of the joint, 1, and maximum 
swelling with possible accumulation or pus, 4. Paralysis and partial 
paralysis were 1 and 0.5 point respectively ~or each limb involved. 
The scores for each rat were totaled and recorded as the degree of 
polyarthritis. The severity of polyarthritis was recorded 3, 4, 5. 
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8, 10 and 14 days following injection of the ~coplasma, and once 
every week, thereafter, for eight weeks. 
Blood samples were collected from each rat (via cardiac punc-
ture) two days prior to inoculation of the animals, and 4, 8, 14 
and 21 days following inoculation. The animals were bled from the 
orbital sinus once a week thereafter for approximately four months. 
The sera were harvested after overnight storage at 4°C and diluted 
1:.5 with modified barbital buffer. The samples were finally stored 
at _200C until used in metabolic inhibition, indirect hemagglutina-
tion or complement fixation tests. 
RESULTS 
10 METABOLIC INHIBITION 
Taylor-Robinson et al. (1966) have shown that neither heated 
nor unheated guinea pig serum have a~ effect on the metabolic inhi-
bition titer of antisera to H. pneumoniae, strain FH, and H. fer.mentans; 
whereas, the inhibitor,y titer of rabbit antiserum against the Negroni 
agent, a strain of H. pulmonis, was markedly increased. It was 
reported by Purcell et al. (1966) that the metabolic inhibition titer 
of rabbit antisera against H. hominis, type I, H. arthritidis, ~. 
salivarium and H. orale. type II was increased when unheated guinea 
pig serum was added to the medium. However. the addition of unheated 
guinea pig serum did not affect the metabolic inhibition titer of 
rabbit antiserum against H. orale, type I. Barker and Patt (1967) 
recently demonstrated the role of complement and antiserum in inacti-
vation of H. gallisepticum. When unheated guinea pig serum was added 
to a oulture of M. gallisepticum in broth containing H. gallisepticum 
antiserum produoed in a rabbit the number of viable organisms fell 
rapidly from 106 to 102 organisms/O.2 rol. No ohange in the number of 
viable organisms ocourred when heated guinea pig serum was added. 
Since the metabolic inhibition titer of antiserum against 
various speoies of ~coplasma is either enhanced or unaffected by 
guinea pig serum, it was necessar,y to determine the effect of guinea 
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pig serum upon M. arthritidis, the organism studied in this thesis. 
The results of an experiment to determine the effect of guinea pig 
serum on the metabolic inhibition titer of antiserum against H. 
arthritidis are presented in Table 1. 
Sinoe there was no difference between the titer of antiserum 
in the presence of heated guinea pig serum or its absence, it seemed 
doubtful that the additional nutrient provided by the serum enhanoed 
~coplasma growth, whioh could lower the metabolic inhibition titer. 
However, the addition of unheated guinea pig serum increased in titer 
at least sixteen fold. This indioated a heat labile acoessory factor 
was involved in the metabolic inhibition test when using H. arthritidis. 
In addition to a heat labile factor, guinea pig serum also oon-
tained a heat stable factor which in low dilution inhibited H. arthri-
tidis, strain 14152, from metabolizing arginine. This inhibition may 
be the result of several factors. First of all, the guinea pig serum, 
in very low dilutions may buffer the medium and prevent the pH from 
ohanging. Secondly. a nonspecific cidal agent or antibody in the 
guinea pig serum may kill the ~ooplasma. A simple procedure was 
used to determine if the organisms in the metabolio inhibition test 
were viable after four days of incubation. No oolonies appeared 
when a drop of the four-day culture containing guinea pig serum in 
a final dilution less than 1:42 was placed on PPLO agar and inoubated 
at 37°0 for four days. Colonies were deteoted when the same prooedure 
was attempted with cultures oontaining heated or unheated guinea pig 
TABLE 1 
Effect of Guinea Pig Serum on the Metabolic Inhibition 
Titer of Rabbit Antiserum Against H. arthritidis, 
strain 141.52 
TEfst system* 
No guinea pig serum 
Heated guinea pig serum 
(0.1 ml of 1:10) 
Unheated guinea pig serum 
(0.1 ml of 1:10) 
0.25 ml of heated guinea pig 
serum; no rabbit antiserum 
0.25 ml of unheated guinea pig 
serum; no rabbit antiserum 








**Reciprocal of the highest dilution of serum which inhibited 
metabolism of arginine and color change of the indicator. 
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It can be seen in Table 2 that there was no difference in the 
metabolic inhibition titer of rabbit antiserum against H. arthritidis, 
strain 14152, when heated or unheated horse serum was used in the 
medium. This may be attributed to the age of the horse serum which 
was stored three to four weeks at 4°c. The labile factor whioh 
Taylor-Robinson detected in horse serum may be absent in the unheated 
horse serum due to loss during storage as well as in the heated horse 
serum. In any event, the addition of fresh guinea pig serum provided 
the heat labile accessory factor missing in horse serum. 
TABLE 2 
Effect of Heated Horse Serum on the Metabolic 
Inhibition of H. arthritidis, Strain 14152, 
by its Homologous Antiserum 
Test system· 
Unheated horse serum 
Heated horse serum 
(1 hr. at 56°c) 




··Reciprocal of the highest dilution of serum which inhibited 
metabolism of arginine and color change of the indioatQr. 
To further study the effect of heated horse serum and guinea 
pig serum on the metabolic inhibition titer of an antiserum against 
H. arthritidis, replicate titrations were performed with and without 
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the addition of fresh guinea pig serum and with heated or unheated 
horse serum. A comparison of the metabolic inhibition titers 
obtained is presented in Table 3. 
In the results shown here unheated horse serum had no sig-
nificant effect upon the metabolic inhibition titer while the 
addition of fresh guinea pig serum to the medium increased the 
metabolic inhibition titer four to eight fold. Unheated horse 
serum was used in subsequent tests since heated horse serum does 
not increase the metabolic inhibition titer of the antiserum. 
Unheated guinea pig serum, likewise, was used in metabolic inhibi-
tion tests but on~ at a final dilution of 1:90 since the serum, 
itself, oauses inhibition of H. arthritidis when diluted less than 
1:41. 
II. ABSORBED RABBIT ANTISERUM 
Rabbit antiserum was absorbed with M. arthritidis, strain 
14152 antigen as desoribed previous~. A metabolic inhibition test 
was prepared using absorbed and unabsorbed antiserum prepared against 
H. arthritidis, strain 14152. The effect of unheated guinea pig serum 
on the metabolic inhibition titer of rabbit antiserum was studied. 
The results of the experiment are presented in Table 4. 
The metabolic inhibition titer of unabsorbed antiserum. was 
increased four fold by the addition of unheated guinea pig serum. 
The metabolio inhibition titer of rabbit antiserum absorbed with 
TABLE 3 
Effect of Heated Horse Serum and Fresh Guinea Pig Serum 
on the Metabolio Inhibition of H. arthritidis, 
Strain 14152, by its Homologous Antiserum 
Test system* 
HHS*** with GPS**** 
HS***** with GPS 
HHS without GPS 
HS without GPS 







**Reoiprooal of the highest dilution of serum whioh inhibited 
metabolism of arginine and oolor ohange of the indioator 
***Ten per oent heated horse serum (heated 1 hour at 56°c) 
****Fresh guinea pig serum (final dilution of 1:90) 
*****Ten per cent unheated horse serum 
TABLE 4 
Effect of Guinea Pig Serum on the Metabolic Inhibition 
of 11. arthritidis, Strain 141,52, by Absorbed 
and Unabsorbed Homologous Antiserum 
Test system. 
Unabsorbed rabbit antiserum 
without guinea pig serum 
Unabsorbed rabbit antiserum 
with guinea pig serum 
Absorbed rabbit antiserum 
without guinea pig serum 
Absorbed rabbit antiserum 
with guinea pig serum 







.*Reciproca1 of the highest dilution of serum which inhibited 
metabolism of arginine and color change of the indicator 
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antigen prepared from~. arthritidis, strain 14152, was decreased 
32 fold when fresh guinea pig serum was omitted from the test system. 
In the presence of guinea pig serum the reduction in metabolic inhi-
bition titer after absorption was 64 fold. This indicated that anti-
body in the rabbit antiserum combined with its homologous antigen and 
was removed when the antiserum-antigen mixture was centrifuged. The 
addition of unheated guinea pig serum had little effect on the 
metabolic inhibition titer when most of the antibody had already 
been removed by absorption with its homologous antigen. However, 
when antiserum against M. arthritidis, strain 14152 was present (as 
in serum not absorbed) unheated guinea pig serum enhanced the titer. 
It is evident that both antibody and unheated guinea pig serum are 
necessary for maximum metabolic inhibition titers. 
III. INDIRECT HEMAGGLUTINATION TEST 
An indirect hemagglutination test was set up as described 
previously using !!. arthritidis, strain 14152, and its homologous 
rabbit antiserum. This test was used to determine the amount of 
antigen required to sensitize tanned sheep erythrocytes and permit 
maximum hemagglutination of the cells by antiserum. The results of 
this test are presented in Table 5. 
Complete agglutination of the erythrocytes occurred when the 
antigen was diluted as much as 1:64 and the rabbit antiserum diluted 
1:12800. 
TABLE 5 
Indirect Hemagglutination Test Using M. arthritiqis, 
Strain 14152, and its Homologous Rabbit Antiserum 
Antigen 
dilution* 8 16 32 (].I, 128 256 512 1024 2O!J.8 0 
Serum 
dilution* 
50 + + + + + .; 
100 + + + + ; 
200 + + + + + .; 
400 + + + + + + .;. 
800 + + + + + + .; 
1600 + + + + + + + + 
3200 + + + + + + + .; 
6400 + + + + + + ;-
12800 + + + + ; .; 
25600 
0 
*Reciprocal of the dilution 
+ = Complete agglutination of the sensitized sheep er,ythrooytes 
- = No deteotable agglutination of the sensitized sheep 
erythrooytes 
.; = 50% agglutination of the sensitized sheep erythrooytes 
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A large amount of sheep erythrocytes were tanned and sensi-
tized with antigen, prepared from H. arthritidis. strain 14152. 
diluted 1:64. These cells were frozen as described previous~ and 
stored at _700 C until used. The frozen sensitized sheep erythrooytes 
were thawed and used in an indirect hemagglutination test. The 
results of this test are presented in Table 6. 
Agglutination of the sensitized sheep erythrocytes occurred 
when the rabbit antiserum was diluted 1:6400. No detectable agglu-
tination ocourred when a rat antiserum was used. 
An indirect hemagglutination test was set up using antigen 
prepared from H. arthritidis, strain 14152, and antiserum collected 
from a rat infected four weeks previously with M. arthritidis, strain 
14152. The sensitized sheep erythrocytes (not frozen) did not agglu-
tinate even at the lowest dilutions of antigen and homologous anti-
serum. 
IV <> MYCOPLASMA ISOLATES FROM RATS 
~coplasma were isolated from tissues of autopsied Long-Evans, 
strain L white and black rats. Some of the ~coplasma isolates were 
tentatively identified by their physiological properties (Table 7). 
others by their colonial morphology (Tabl~ 8). 
Organisms which had smooth, distinct central regions of growth 
into the agar were tentatively identified as H,. arthritidis. Those 
with gold, rough, and indistinct centers were identified as 11. 
TABLE 6 
Indireot Hemagglutination of Sensitized Sheep 
Erythrocytes* Using Rabbit and Rat Antiserum 
Against M. arthritidis, Strain 14152 
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Sensitized SE with 
rabbit antiserum 
Sensitized SE with 
rat antiserum. 
+ + + + + + + + 
.Sheep erythrocytes had been sensitized with antigen prepared 
from H. arthritidis, strain 14152 diluted 1:64 and frozen • 
• *Reciprocal of the dilution 
***Sheep erythrocytes 
TABLE 7 
Physiological Properties of MYcoplasma Isolated From Rats 
Isolate* Colonial Arginine Gluoose Egg Benzidine TTC** TTC** Probable organism 
morphology broth broth yolk blood aarob. anaer. 
29G smooth, dis- + + .!1. arthritidis 
tinct center 
29L smooth, dis- + + !1. arthritidis 
tinct oenter 
3lC smooth, dis- + + H. arthritidis 
tinct center 
3lE smooth, dis .. + + H. arthritidis 
tinct center 
3lG smooth, dis- + + H. arthritidis 
tinot center 
31H smooth, dis- + + 11. arthritidis 
tinct oenter 
311 smooth, dis- + + !1. arthritidis 
tinct center 
31L smooth. dis- + + H. arthritidis 
tinct center 
\.U 
32G smooth, dis- + + H. arthritidis ......:2 
tinct center 
TABLE ? (Continued) 
Isolate* Colonial Arginine Gluoose Egg Benzidine TTC** TTC** Probable organism 
morphology broth broth yolk blood aerobe anaer. 
32H smooth, dis- + + 11. arthritidis 
tinot center 
33A gold, indis- + + + + + li. 1)ulmonis 
tinct center 
33B gold, indis- + + + + + li. 'J)ulmonis 
tinct oenter 
33C gold, indis- + + + + + H. 1)ulmonis 
tinct center 
331 smooth, dis- + + H. arthritidis 
tinot oenter 
33J smooth, dis- + + li. arthritidis 
tinct center 
33M smooth, dis- + + H. arthritidis 
tinct center 
*Number of rat and tissue from whioh the mycoplasma was isolated: saliva (A), nasal mucosa 
(B), lung (e), traohea (D), bladder (E), cecal material (F), liver (G), spleen (H), joint (1). 
~ph nodule (J), heart (1), kidney (L) or joint streaked onto sheep blood agar (M) 
























Colonial Characteristics of ~coplasma Isolated 
From Rats Subject to Spontaneous Arthritis 
Colonial morphology 
gold, rough, indistinct center 
gold, rough, indistinct center 
smooth, distinct center 
smooth, distinct center 
smooth, distinct center 
gold, rough, indistinct center 
ver,y small colo~; no noticeable center 
gold, rough, distinct center 
smooth, distinct center 
smooth, distinct center 
ver,y small colony; no noticeable center 
gold. rough, indistinct center 
smooth, distinct center 
smooth, distinct center (small colony) 
smooth, distinct center (small eolo~) 
smooth, distinct center 
gold, rough, indistinct center 
smooth, distinct center 
smooth, distinct center 
smooth, distinct center 
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*Number of rat and tissue from which the ~coplasma was isolated; 
saliva CAl, nasal mucosa (B), lung (C), trachea (D), bladder (E), cecal 
material (F), liver (G), spleen (H), joint (I), lymph nodule (J), heart 
(I) t kidney (L). 
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pu1m.onis. Most of the rats harbored both H. arthritidis and H. 
pu1m.onis, the former being present in almost every tissue cultured. 
This indicated the possibility that septicemia occurred with H. 
arthritidis and distributed organisms in the various organs and tis-
sues. H. pulmonis, however, was only isolated from ~aliva, nasal 
mucosa, and lung. This indicated that the organism was harbored in 
the oral and nasal cavities. 
V. INTRAVENOUS INOCULATION OF RATS WITH !1. ARTHRITIDIS 
Sera collected from rats inoculated with H. arthr1tidis, strain 
1.58, were tested for complement fixing antibody. The results of the 
complement fixation tests are presented in Tables 9-13. T~e degree of 
po~arthritis involvement was recorded in Tables 14.17. 
The complement fixation titers of sera from animals injected 
intravenous~ with equal numbers of organisms were averaged and plotted 
against time in Figures 1-4. An average po~arthritis score is also 
shown in the SQe figures. 
Complement fixing antibodies produced by rats in response to 
intravenous inoculation with H. arthritidis, strain 158, were corre-
lated with the number of CFU of the organism injected. When 6%106 or 
6%107 CFU of H. arthritidis were injected, arthritis was miniJaal and 
the complement fixation titers reached their maximum between fifty 
and sixty days after injection. However, when rats were inooulated 
with 6xl08 or 6xl09 CFU of H. arthritidis, complement fixation titers 
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TABLE 9 
Complement Fixation Titers of Sera Obtaiged From 
Rats Injected Intravenous~ with 6xl0 CFU 
of H. arthritidis, Strain 158 
Days after Complement fixation titer* 
inooulation 54** 57 61 64 67 
0 10 10 10 10 10 
4 80 160 80 320 1280 
8 320 160 40 1280 2560 
14 160 2560 20 2560 5120 
21 160 40 1280 2560 
28 10 320 40 1280 320 
35 5120 40 2560 640 
42 2560 80 10240 640 
49 10240 10 1280 640 
56 2otJ.80 20 1280 2560 
63 1280 10 160 640 
92 320 320 
147 320 320 
*The reciprocal of the greatest dilution of ~erum which inhibited 
oomplete ~sis of sheep erythrooytes. 
**Animal number 
TABLE 10 
Complement Fixation Titers of Sera Obtained From Rats Injected 
Intravenously with 6xl07 CFU of H. arthritidis, strain 15S 
Days after Complement fixation titer* 
inoculation 47** 35 36 37 38 41 42 44 45 49 .51 
0 10 10 10 10 10 10 10 10 10 10 10 
4 640 640 12S0 1280 12S0 2560 320 320 1280 5120 5120 
8 640 5120 5120 640 640 5120 640 640 12S0 2560 
14 (#0 2560 2560 5120 2560 640 
21 1280 5120 10240 2560 2 (){I. 8 0 640 1280 640 2560 1280 640 
28 2560 2560 2560 1280 640 640 160 1280 160 1280 80 
35 10240 1280 5120 2~80 160 5120 640 5120 1280 5120 )20 
42 10240 5120 2;60 2~80 10240 2.560 2560 2 (){I. 8 0 10240 1280 2.560 
49 2560 2~80 1280 1280 10240 2 (){I. 8 0 1280 40960 10240 640 2560 
56 5120 2(){1.S0 40960 10240 5120 10240 2560 40960 1280 2560 
63 5120 40960 2560 5120 1280 10240 160 10240 1280 
92 5120 2560 
.Reciproca~ ot the greatest dilution ot serum which inhibited oomplete lysis of sheep 
erythrocytes. 





Complement Fixation Titers of Sera Obta~ned From 
Rats Injected IntravenouslY with 6x10 CFU of 
.H. arthritidis, Strain 158 
Days after Complement fixation titer* 
inoculation 19** 23 24 28 33 
0 10 10 10 10 10 
4 2560 1280 2560 2560 1280 
8 2560 5120 2560 5120 20480 
14 20480 20480 20480 5120 
21 10240 10240 2560 1280 2560 
28 40960 1280 5120 5120 5120 
35 20480 5120 2560 40960 1280 
42 40960 2560 2560 10240 5120 
49 40960 2560 2560 20480 10240 
56 40960 10240 2~80 40960 1280 
63 5120 5120 .5120 640 20480 
92 640 320 2560 10240 
147 160 320 640 2560 
*Reciproca1 of the greatest dilution of serum which inhibited 
oomp1ete lYsis of sheep erythrocytes. 
** Animal number 
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TABLE 12 
Complement Fixation Titers of Sera Obtained From 
Rats Injected Intravenous~ with 6%109 CFU of 
~. arthritidis, Strain 158 
Days after Complement fixation titer* 
inoculation 72** 7J 74 78 81 
0 10 10 10 10 10 
4 80 10240 10240 
8 1280 2560 2560 
14 1280 )20 5120 
21 1280 10240 1280 2560 2~80 
28 160 640 640 5120 1280 
35 40960 2(#80 40960 2~80 .5120 
42 2(#80 10240 10240 10240 2~80 
49 2560 2(#80 10240 1280 40960 
56 20480 10240 40960 5120 20480 
63 2(#80 10240 .5120 2560 40960 
92 2560 5120 640 
147 1280 2560 640 
.Reciprocal of the greatest dilution of ser~ whiph ~nhibited 
complete ~sis of sheep erythrocytes. 
** Animal number 
TABLE 13 
Complement Fixation Titers ot Sera Obtained From Rats 
Injected Intravenous~ with 0.5 m1 ot PPLO Broth 
Days atter Complement tixation tite~* 
inoculation 3** 4 7 8 9 10 12 16 
42 10 10 10 10 10 20 10 10 
49 10 10 10 10 10 10 10 10 







.Reciproca1 ot the greatest dilution ot serum which inhibited 
complete lysis ot sheep erythrocytes 
*. Animal number 
TABLE 14 
Polyarthritis Following Intravenous Injection ot 
6x106 CFU ot H. arthritidis. Strain 1.58 
Days atter Polyarthritis score* Average po~arthritis 
inoculation .57** 61 64 67 sCQre·** 
3 0 0 0 0 0 
4 0 0 0 0 0 
5 0 0 0 0 Q 
8 0 0 0 0 0 
10 0 0 0 0 0 
14 0 0 0 0 0 
21 0 0 0 0 0 
51 0 0 0 0 0 
*The involvement ot polyarthritis was determined by es~imating 
the swelling ot each joint and reoording this on a scale ot 1 to 4. 
Paralysi~ and partial paralysis were 1 and 0 • .5 respectively tor each 
limb. The scores were totaled and recorded as po~art~itis. 
**Ani.ma1 number 
***Qbtained by averaging polyarthritis scores ot indi"idua1 
animals at indicated times 
TABLE 15 
Polyarthritis Following Intravenous Injection of 
6xl07 CFU of M. arthritidis, Strain 158 
46 
Days after Po~arthritis score* Average 
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.The involvement of po~arthritis was determined by estimating 
the swelling of eaoh joint and reoording this on a scale of 1 to 4. 
Para~sis and partial paralysis were 1 and 0.5 point respeotively for 
each limb, The soores were totaled and recorded as polyarthritis. 
** Animal number 
**~btained by averaging polyarthritis scores of individual 
animals at indicated times 
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TABLE 16 
Polyarthratis Following Intravenous Injection of 
6xlO CFU of !. arthritidis, Strain 158 
Days after Polyarthritis score* Aver~, pqlyarthritis 
inoculation 23** 19 24 28 32 score*** 
3 4 0 1 0 0 1.0 
4 2 2 1 2 5 2.4 
5 3 2 0 2 5 2.4 
8 5 2 0 2 3.5 2.5 
10 6 2.5 3.5 2.5 4 3.2 
14 2 2.; 2 2 1 2.0 
21 :3 2.5 0 0 4 2,0 
31 0 1 0 0 1 0.4 
40 0 0 1 2 0 0.6 
51 0 0 0 0 0 0 
*The involvement of polyarthritis was determined QY estimating 
the swelling of each joint and recording this on a ~Qale of 1 to 4, 
Paralysis and partial paralysis were 1 and 0.5 point respeotively for 
each limb. The scores were totaled and recorded as polyarthritis. 
** Animal number 
***Obtained by averaging polyarthritis scores of individual 
animals at indicated times 
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TABLE 17 
Po~arthritis Following Intravenous Injection ot 
6xl09 CFU ot !I. arthritidis, Strain 158 
Days atter Polyarthritis score* Averag. polyarthritis 
inoculation 72** 73 74 78 81 seoJ"e*** 
3 2 1 5 3.5 6 3.4 
4 10 2 4 5 12 6.6 
5 5.5 6 10 7 11 8.0 
8 9 4 19 11 14 1l,4 
10 8 8 22 7 8 8.6 
14 6 6 13 6.5 6 7.4 
21 3 4.5 7 4 6 4.8 
31 2 1.5 4 2 5 3.0 
40 0 0 1 2 1 0.8 
51 0 0 1 1 1 0.6 
.The involvement of polyarthritis was determined by estimating 
the swelling of each joint and recording this on a scale of 1 to 4. 
Paralysis and partial paralysis were 1 and 0.5 point respectively for 
each limb • The scores were totaled and recorded as polyarthritis. 
•• Animal number 
* •• Obtained b,y averaging polyarthritis scores of individual 
animals at indicated times 
Figure 1. Average complement fixation titers of sera collected from rats injected with 6xl06CFU 
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Figure 20 Average complement fixation titers of sera collected from rats injected with lxl07CFU 
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rose to high levels within eight days after injection, at a time 
when polyarthritis was maximal; and these complement fixation titers 
remained at a high level through the sixtieth day. 
Polyarthritis occurred on the third day after intravenous 
injection of the rats with the suspension of ~coplasma and reached 
a maximum between seven and fourteen days. It declined gradually 
and had completely disappeared by the sixth or seventh week. Here 
again, the response was directly related to the size of the inoculum. 
Animals injected with 6xl09 or 6xl08 CFU of the organisms had exten-
sive polyarthritis which lasted five to six weeks; while polyarthritis 
in animals inoculated with 6xl06 or 6xl07 CFU was less severe and 
lasted three to six weeks. Individual animals within each group 
varied considerably. For example, some serum samples, collected 21 
days after a rat was injected with 6xl09 CFU, fixed complement when 
diluted 1:1280; while serum samples from another rat ~jected with 
the saxne number of organisms fixed complement when diluted 1:10240. 
There was an eight-fold difference between the two titers. 
A. large number of rats was used in the experiment where rats 
were inoculated intravenously with var,ying numbers of M. arthritidis 
to offset biological variability. However, approximately l~ of the 
animals died when bled by cardiac puncture. This greatly reduced 
the number of animals being tested. 
VI. CHALLERJE WITH H. ARTHRITIDIS 
Nine weeks after the first injection of rats with M. arthritidis, 
the surviving animals were divided into two groups. Thirteen of the 
animals were used to complete the study on complement fixing antibody. 
Blood samples were collected approximately every two weeks and tested 
for complement fixing antibody. The remaining fourteen animals were 
challenged with 1.8rl010 CFU of H. arthritidis, strain 158. The 
animals, which had previously been injected with PPLO brotht were 
injected intravenously with either 1.8x1010 CFU of H. arthritidis, 
strain 158, or PPLO broth. Ten normal rats, weighing 350 to 400 grams 
(the weight of the animals previously inoculated with H. arthritidis)t 
were also injected intravenously with 1.8xl010 CFU of !. arthritidis, 
strain 158. The severity of polyarthritis for each animal is shown in 
Tables 18-21. 
One of fourteen animals which had been inoculated with H. 
arthritidis, strain 158, and challenged with the same organi,m nine 
weeks later contracted polyarthritis. This animal did not have poly-
arthritis after primary injection of B. arthritidis, but did have a 
low complement fixing antibo~ response which reached a maximum of 
1:80 and fell to 1:10 prior to challenge with H. arthritidis. Several 
other rats had not exhibited polyarthritis on primary injeotion. They 
did not exhibit polyarthritis when challenged with H. artbritidis. 
On primary injection of 6x107 and 6x108 CFU of H. arthritidis, 
strain 158, 8~ and 10~ of the animals, respectively, developed 
TABLE 18 
Po~arthritis Following Intravenous Injection of Normal 
Rats with 1.8xl010 CFtJ of !. arthritidis, Strain 158 
55 
Days after Po~arthritis score. Average po~-
inoculation 86·· 87 88 89 90 91 92 93 94- 95 arthritis 
score*·· 
3 22 21 23 25 21 22 31 12 14 28 19.8 
4 44 38 33 51 42 46 63 20 25 53 41.5 
8 :A- 49 75 48 77 79 41 48 81 61.3 
*The involvement of po~arthritis was determined by estimating 
the swelling of each joint and recording this on a scale of 1 to 4. 
Para~sis and partial para~sis were 1 and 0.5 point respective~ for 
each limb. The sOores were totaled and recorded a~ po~arthritis. 
**Animal number 
.··Obtained by averaging po~arthritis scores of individual 
animals at indicated times 
TABLE 19 
PolYarthritis of Rats Injected Intravenous~ with PPLO Broth and 
Challenged Nine Weeks Later with an Intravenous Injection 
of 1.8xl010 CFU of M. arthritidis, Strain 158 
Days after PolYarthritis score* Average ~o~arthritis 
challenge 4** 5 7 8 9 10 score·*· 
3 37 42 24 28 21 8 26.7 
4 80 67 40 55 22 53.0 
8 99 82 25 :A- 30 58.0 
*The involvement of polYarthritis was determined by estimating 
the swelling of each joint and recording this on a scale of 1 to 4. 
ParalYsis and partial paral.ysis were 1 and 0.5 point respective~ for 
each limb. The scores were totaled and recorded as polYarthritis. 
** Animal number 
•• *Obtained by averaging polYarthritis scoreS of individual 
animals at indicated times 
TABLE 20 
Po~arthritis of Animals Injected Intravenous~ wit~ 
PPLO Broth and Challenged Nine Weeks Later with 
Another Intravenous Injection of PPLO Broth 
56 
Days after Po~arthritis score* Average polyarthritis 
16 challenge 12·· 17 score··· 
3 0 0 0 0 
4 0 0 0 
8 0 0 0 
.The involvement of polYarthritis was determined by estimating 
the swelling of each joint and recording this on a scale of 1 to 4. 
Para~sis and partial para~sis were 1 and 0.5 point respective~ for 
each limb. The soores were totaled and recorded as po~arthritis • 
•• Animal number 
••• Obtained by averaging po~arthritis scores of individual 
animals at indicated times 
TABLE 21 
Po~arthritis of Animals Injected IntravenouslY with ~. arthritidis. 
Strain 158. and Challenged Nine Weeks Later with an 
Intravenous Injection with the Same Organi~m 
Days after ~olYarthritis score· Average 
challenge 19*· 21 35 36 37 38 42 45 49 61 73 81 83 po~arthr1tis 
score··· 
3 0 0 0 0 0 0 0 0 o 22 0 1 0 1.7 
4 0 0 0 0 0 0 0 0 041 0 0 0 :3 
8 0 0 0 0 0 0 0 0 o 43 0 0 0 3 
*The involvement of po~arthr1tis was determined by estimating 
the swelling of each joint and recording this on a scale of 1 to 4. 
Para~sis and partial paralysis were 1 and 0.5 point respective~ for 
each limb. The scores were totaled and recorded as polyarthritis • 
•• Animal number 
••• Obtained by averaging po~arthritis scores of individual 
animals at indicated times 
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polyarthritis. Challenge of these animals with 1.8xlol° CFU (approx-
imately 800 ED50) did not induce polyarthritis. 
Metabolic inhibition and complement fixation tests were set 
up with rat sera collected 28 days after inoculation of the rats with 
K. arthritidis. strain 158. The results of this test are presented 
in Table 22. 
TABLE 22 
Metabolic Inhibition and Complement Fixation Titers 
of Rat Sera Collected 28 Days After Inoculation 
of Rats with ,H. arthritidis 
Animal number HI titer* CF titer** 
19 10 40960 
23, 36 10 1280 
24, 28, 33 10 5120 
34 10 2560 
37, 38 10 640 
*ReciprQcal of the highest dilution of serum which inhibited 
color change of the indicator 
**Reciprocal of the highest dilution of serum which inhibited 
complete lysis of sheep er,ythrocytes 
It oan be seen in Table 22 that ratB inoculated with !!. 
arthritidis did not produce detectable amounts of metabolic inhibiting 
antibody. Rat sera whioh had a high complement fixation titer had no 
metabolic inhibition titer. 
DISCUSSION 
Homologous antibody plus fresh guinea pig serum can cause ~sis 
of gram-negative bacteria. spheroplasts. protoplasts and mammalian 
erythrocytes (MUschel and Jackson, 1966). Since cell mempranes of 
D\Ycoplasma ar., morphologically similar to membranes of mammalian 
cells (Domermuth et al., 1964) t complement may play an important 
role in the inactivation of D\Ycoplasma. 
From the results presented in this thesis it can be seen that 
the metabolic inhibition titer of rabbit antiserum prepared against 
M. arthritidis, strain 141.52, was greatly increased by the addition 
of fresh guinea pig serum. When fresh guinea pig serum heated at 
S6°c for 30 minutes was used, the metabolic inhibition titer was 
no higher than when guinea pig serum was omitted from the metabolio 
inhib~tion test system. This confirmed the observation of others 
that a heat labile accessor.y factor in fresh guinea pig serum 
increased the metabolic inhibition titer of antiserum prepared 
against various D\Ycoplasma species (Barker and Patt. 1967; Purcell 
et al., 1966; Taylor-Robinson et al •• 1966). 
It was found that metabolic inhibition tests in which the 
indicator had not changed color did not contain viable organisms. 
In other words, the myeoplasma which were inoculated into the 
metabolic tnpibition test system were not onlY inhibited in the 
S9 
metabolism of arginine, as indicated by failure of the indioator 
to ohange color, but were apparently killed. This adds support to 
the work of Barker and Patt (1967) who reported that H. salli~ 
septioum was killed by the addition of homologous antiserUDl and 
oomplement. 
The addition of fresh guinea pig serum to antiboqy-sensitized 
gram-negative baoteria results in the release of ribonuoleio acid 
and deoxyribonucleic aoid, presumably by disrupting permeability 
control mechanisms of the oell (Spitznagel, 1964). A heat labile 
substanoe in fresh guinea pig serum oauses lesions in the oell 
membranes of sheep erythrooytes which have been sensitized with 
antiserum (Borsos et al., 1964). It is possible that a similar 
mechanism is involved in the metabolio inhibition test. AntiboQy 
oould attaoh to the ~ooplasma, then in the presenoe of fresh 
guinea pig serum, result in inoreased permeability of the cell or 
lysis of the oell membrane. The effeots desoribed oould result in 
loss of internal oomponents and inability of affected organtsms to 
oarry on normal metabolio processes. 
Both heated and fresh guinea pig serum in low dilution were 
shown to prevent metabolism of arginine by ~. arthritidis. It seemed 
possible that antibodies in low titer in the fresh guinea pig serum 
reacted with H. arthritidis oausing inhibition of metabolism of argin-
ine by the organism. The metabolism of arginine by ~. arthritidis, 
however, was also inhibited when fresh guinea pig serum. in low 
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dilutions was absorbed with antigen prepared from H. arthrit id is , 
strain 14152. This diminished the possibility that metabolic inhibit-
ing antibodies for ~. arthritidis were present in fresh guinea pig 
serum. It seemed likely a nonspecific inhibitor in the serum caused 
metabolic inhibition of the organisms. 
The metabolic inhibition titer of unabsorbed rabbit antiserum 
against 11. arthritidis t strain 14152, was increased tour fold by the 
addition of fresh guinea pig serum. Rabbit antiserum which had been 
absorbed with I. arthritidis, strain 14152, antigen no longer inhibited 
metabolism of arginine to the extent of unabsorbed antiserum. The 
titer deoreased 64 fold even when fresh guinea pig serum was added to 
the test system. This indicated that specific antibody tor !. 
arthritidis was removed when the antigen-antiserum mixture ~s oen-
trifuged. The addition of fresh guinea pig serum. had little effect 
on the metabolic inhibition titer when most of the antibody had already 
been removed by absorption with its homologous antigen. However, when 
unabsorbed antiserum against B. arthritidis, strain 14152, was present, 
fresh guinea pig serum enhanced the titer. It is evident that both 
antibody and fresh guinea pig serum are necessary tor maximum meta-
bolic inhibition titers. 
It is po~tulated that intravenous injection of H. arthritidis 
into the rat results in po~thritis when the organisms survive 
natural defenses of the host and become lodged in the joint tissue. 
There they grow and possibly produce a substance which accumulates 
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and causes inflammation. This substance may be enzymes or toxins 
produced by the ~coplasma or the ~coplasma, themselves. Since 
rats subject to spontaneous polyarthritis harbor H. arthritidis and 
exhibit signs of polyarthritis only when subjected to unfavorable 
environmental conditions or injury, it seems likely that stress 
permits or even enhances the growth of ~. arthritidis. In the 
experimental situation where large numbers of ~coplasma are required 
to produce polyarthritis, a hypothetical substance postulated as 
responsible for arthritis could accumulate at a rate dependent upon 
the number of organisms injected. Polyarthritis would then occur 
in a shorter period of time and be more severe when large numbers of 
~coplasma are injected into the rat. After intravenous injeotion 
of M. arthritidis the rat may produce antibodies against the organisms 
or their products. Polyarthritis became most severe 7 to 10 days 
after the rats were inoculated. Antiboqy may eventually aid in the 
animals' reoover.y and subsequent resistance to challenge with H. 
arthritidis, since preliminar,y experiments disclosed that uninocu-
lated rats could be passively protected against an intravenous 
challenge inoculum of live H. arthritidis when given serum from rats 
that had recovered from arthritis. In spite of the demonstration of 
passive protective properties in such rat serum, no metabolio inhibit-
ing antibodies could be demonstrated in the serum. Thus an enigmatic 
situation may exist wherein animals are passively protected by serum 
from rats that recovered from arthritis; yet, no antiboqy could be 
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demonstrated that correlated with the protective properties of the 
serum. The serum used in the passive protection tests had high 
titers of complement fixing antibody but the latter may not neces-
sarilY be related to passive protection of the rat from arthritis. 
It is possible that the passive protective properties of the rat 
serum may have been due to an antibody not detectable by the meta-
bolic inhibition test. It also seems reasonable to speculate that 
the complement fixing antibodies present in the serum have nothing 
to do with the ability of these organiSms to metabolize arginine. 
The site of inhibition of metabolism of arginine by metabolic 
inhibiting antiboqy presumab~ is the ~coplasma cell membrane 
(Purcell, 1966). Recent studies of human diploid fibroblasts in 
tissue culture suggest that contact of one fibroblast with another 
is sufficient to inhibit cell metabolism. The cell membrane plays 
an important role in regulating the synthesis of cell constituents 
and factors which influence the cell membrane also affect cell 
metabolism (Eagle, 1965). 
The complement fixation titer of sera collected from rats 
injected intravenouslY with H. arthritidis, strain 158. was directlY 
related to the number of organisms injected. The highest complement 
fixation titer occurred in rats which were inoculated with 6xl09 CFU 
of H. arthritidis. RelativelY low titers occurred in rats inoculated 
with 6xl06 CFU of H. arthritidis. ApproximatelY 6xl07 CFU of H. 
arthritidis injected intravenouslY were necessary to cause polYarthritis 
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in rats. The severity of po~arthritis is direct~ proportional to 
the number of organisms injected into the rat 0 The most severe po~­
arthritis occurred in rats inoculated with 6x109 CFU. 
Since large inocula of !1. arthritidis are required for po~­
arthritis to develop and since polYarthritis does not occur until 
three to four days after injection of the organisms, it seems plausable 
that the organisms produce a substance which must accumulate to cause 
polYarthritis. This substance may be part of the ~coplasma or an 
exotoxin produced by them. ~coplasma have recentlY been shown to 
produce toxins. Thomas (1967) reported that M. neuro~yticumt the 
agent responsible for rolling disease in mice and rats, produces a 
filterable exotoxin in broth cultures. H. gallisepticum (Thomas, 
1967) which has caused outbreaks of encephalitis in turkeys may con-
tain or produce a neurotoxin which when injected intravenouslY into 
turkeys has a toxic action on the arteries of the brain. 
Spontaneous polYarthritis in rats occurs o~ when the animal 
has been subjected to environmental stress. It is possible that 
~coplasma organisms harbored in the tissue of the rat grow in 
necrotic tissue producing the substance which causes po~arthritis. 
Experimental rats, which had been injected intravenouslY with H. 
arthritidis t were resistant to intravenous challenge with the same 
organism. Resistance may be a result of antibody formed in response 
to products of the mycoplasma. It was shown that complement fixing 
antibodies were present within four days after intravenous injection 
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of rats with H. arthritidis. These antibodies did not protect the 
animals from polyarthritis since severe arthritis occurred when the 
complement fixation titer was rising. When 6xl06 or 6xl07 CFU of 
I. artbritidis were injected, arthritis was minimal and. the complement 
fixation titers reached their maximum. between 50 and 60 days after 
injection. However, when rats were inoculated with 6xl08 or 6xl09 CFU 
of H. arthritidis, complement fixation titers rose to high levels with-
in eight days after injection at a time when polyarthritis was maximal 
and these complement fixation titers remained at a high level through 
the sixtieth day. Antibody against the substance or sUbstances which 
caused po~arthritis may not be measured by the complement fixation 
test sinoe a complement fixation titer occurred eVen before arthritis 
developed. According to Raffel (1961) complement fixing antibody has 
little or no relationship to the mechanisms of acquired resistance in 
bacterial infections. The observations reported here certai~ sup-
port Raffel's contention. Animals are known to respond. to some anti-
genic stimuli by the production of antibody whioh cannot be revealed 
by the serologic tests employed for the purpose (Raffel, 1961). 
Whether or not such antibody could function in a protective capacity 
in vivo without serological activity in vitro is not known. It should 
be pointed out, however, that the production of the antiserum. against 
M. arthritidis, strain 14152, in the rabbit made use of multiple 
-
injections of killed organisms given with Freund's complete adjuvant. 
This rabbit antiserum. did exhibit metabolic inhibiting antibodies in 
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high titer. The rat antiserum was produoed following a single intra-
venous injection of living ~coplasma. Thus, the observations dis-
oussed here oould have been due to differences in route of injection, 
differences in type of antigen and differences in the species of 
animal used. 
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